Out Now: 2 Stocks to Ride India's EV Megatrend
Here is the latest financial fact sheet of CIPLA. For more details, see the CIPLA quarterly results and CIPLA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.0 |
No. of shares | m | 807.22 |
1 Week | % | 2.5 |
1 Month | % | 6.4 |
1 Year | % | -1.3 |
52 week H/L | Rs | 1,185.2/852.0 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
CIPLA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 663 | 678 | 586 | 879 | 1,083 | |
Low | Rs | 479 | 484 | 357 | 411 | 806 | |
Sales per share (Unadj.) | Rs | 187.5 | 203.1 | 212.5 | 237.6 | 269.7 | |
Earnings per share (Unadj.) | Rs | 17.6 | 18.7 | 19.2 | 29.8 | 31.7 | |
Diluted earnings per share | Rs | 17.6 | 18.7 | 19.2 | 29.7 | 31.7 | |
Cash flow per share (Unadj.) | Rs | 34.1 | 35.2 | 33.8 | 43.0 | 44.8 | |
Dividends per share (Unadj.) | Rs | 3.00 | 3.00 | 4.00 | 5.00 | 5.00 | |
Adj. dividends per share | Rs | 2.99 | 2.99 | 4.00 | 5.00 | 5.00 | |
Avg Dividend yield | % | 0.5 | 0.5 | 0.8 | 0.8 | 0.5 | |
Book value per share (Unadj.) | Rs | 175.9 | 185.6 | 194.9 | 226.7 | 257.8 | |
Adj. book value per share | Rs | 175.5 | 185.3 | 194.6 | 226.5 | 257.6 | |
Shares outstanding (eoy) | m | 805.12 | 805.70 | 806.24 | 806.46 | 806.81 | |
Price / Sales ratio | x | 3.0 | 2.9 | 2.2 | 2.7 | 3.5 | |
Avg P/E ratio | x | 32.4 | 31.0 | 24.6 | 21.6 | 29.8 | |
P/CF ratio (eoy) | x | 16.8 | 16.5 | 14.0 | 15.0 | 21.1 | |
Price / Book Value ratio | x | 3.2 | 3.1 | 2.4 | 2.8 | 3.7 | |
Dividend payout | % | 17.0 | 16.0 | 20.8 | 16.8 | 15.8 | |
Avg Mkt Cap | Rs m | 459,723 | 468,032 | 379,858 | 519,826 | 762,177 | |
Total wages/salary | Rs m | 26,901 | 28,565 | 30,270 | 32,518 | 35,299 |
CIPLA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 150,922 | 163,624 | 171,320 | 191,596 | 217,633 | |
Other income | Rs m | 3,577 | 4,766 | 3,694 | 2,698 | 3,217 | |
Total revenues | Rs m | 154,498 | 168,390 | 175,014 | 194,294 | 220,851 | |
Gross profit | Rs m | 27,489 | 30,973 | 31,808 | 42,487 | 43,298 | |
Depreciation | Rs m | 13,228 | 13,263 | 11,747 | 10,677 | 10,520 | |
Interest | Rs m | 1,142 | 1,684 | 1,974 | 1,607 | 1,064 | |
Profit before tax | Rs m | 16,695 | 20,791 | 21,782 | 32,901 | 34,933 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,501 | 5,695 | 6,312 | 8,888 | 9,338 | |
Profit after tax | Rs m | 14,194 | 15,096 | 15,470 | 24,013 | 25,595 | |
Gross profit margin | % | 18.2 | 18.9 | 18.6 | 22.2 | 19.9 | |
Effective tax rate | % | 15.0 | 27.4 | 29.0 | 27.0 | 26.7 | |
Net profit margin | % | 9.4 | 9.2 | 9.0 | 12.5 | 11.8 |
CIPLA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 108,141 | 124,246 | 117,038 | 131,810 | 147,108 | |
Current liabilities | Rs m | 38,322 | 37,715 | 43,931 | 45,911 | 49,129 | |
Net working cap to sales | % | 46.3 | 52.9 | 42.7 | 44.8 | 45.0 | |
Current ratio | x | 2.8 | 3.3 | 2.7 | 2.9 | 3.0 | |
Inventory Days | Days | 49 | 71 | 47 | 65 | 62 | |
Debtors Days | Days | 8 | 9 | 8 | 7 | 6 | |
Net fixed assets | Rs m | 118,588 | 113,353 | 117,166 | 116,277 | 119,248 | |
Share capital | Rs m | 1,610 | 1,611 | 1,613 | 1,613 | 1,614 | |
"Free" reserves | Rs m | 140,019 | 147,941 | 155,487 | 181,232 | 206,364 | |
Net worth | Rs m | 141,629 | 149,552 | 157,100 | 182,844 | 207,977 | |
Long term debt | Rs m | 36,621 | 38,301 | 23,693 | 12,028 | 4,162 | |
Total assets | Rs m | 226,729 | 237,619 | 234,228 | 248,372 | 266,523 | |
Interest coverage | x | 15.6 | 13.3 | 12.0 | 21.5 | 33.8 | |
Debt to equity ratio | x | 0.3 | 0.3 | 0.2 | 0.1 | 0 | |
Sales to assets ratio | x | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
Return on assets | % | 6.8 | 7.1 | 7.4 | 10.3 | 10.0 | |
Return on equity | % | 10.0 | 10.1 | 9.8 | 13.1 | 12.3 | |
Return on capital | % | 10.0 | 12.0 | 13.1 | 17.7 | 17.0 | |
Exports to sales | % | 33.1 | 33.9 | 32.2 | 31.3 | 26.2 | |
Imports to sales | % | 13.9 | 11.6 | 3.4 | 10.9 | 8.2 | |
Exports (fob) | Rs m | 49,883 | 55,419 | 55,175 | 59,951 | 57,094 | |
Imports (cif) | Rs m | 21,033 | 19,041 | 5,903 | 20,911 | 17,803 | |
Fx inflow | Rs m | 51,691 | 57,410 | 56,036 | 68,051 | 60,180 | |
Fx outflow | Rs m | 21,033 | 19,041 | 5,903 | 20,911 | 17,803 | |
Net fx | Rs m | 30,658 | 38,368 | 50,133 | 47,140 | 42,376 |
CIPLA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 14,628 | 16,911 | 30,685 | 37,552 | 33,259 | |
From Investments | Rs m | -8,540 | -16,687 | 1,040 | -23,872 | -18,719 | |
From Financial Activity | Rs m | -3,855 | -3,487 | -29,488 | -12,395 | -15,998 | |
Net Cashflow | Rs m | 2,431 | -3,451 | 2,340 | 1,413 | -1,323 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Y K Hamied | COMP SEC: Rajendra Chopra | YEAR OF INC: 1935 | BSE CODE: 500087 | FV (Rs): 2 | DIV YIELD (%): 0.5 |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA PIRAMAL ENTERPRISES LUPIN ZYDUS LIFESCIENCES DR. REDDYS LAB
Compare CIPLA With: AUROBINDO PHARMA PIRAMAL ENTERPRISES LUPIN ZYDUS LIFESCIENCES DR. REDDYS LAB
On Monday, Indian share markets continued their momentum as session progressed and ended the day higher.